| 1 |
34591162 | Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies. | 2022 Jan |
1 |
| 2 |
35205845 | Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry. | 2022 Feb 21 |
1 |
| 3 |
35218068 | Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/-plerixafor vs cyclophosphamide/GCSF+/-plerixafor. | 2022 Feb 26 |
1 |
| 4 |
33146835 | Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer. | 2021 Jul |
1 |
| 5 |
33585350 | Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy. | 2021 Feb |
1 |
| 6 |
33880064 | Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic. | 2021 |
1 |
| 7 |
34870568 | Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy. | 2021 Dec 6 |
1 |
| 8 |
32499108 | A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis. | 2020 Oct |
1 |
| 9 |
32586769 | Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma. | 2020 Oct |
2 |
| 10 |
32615949 | Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization. | 2020 Jul 2 |
1 |
| 11 |
32717620 | Review of conditioning regimens for haplo-identical donor transplants using post-transplant cyclophosphamide in recipients of G-CSF mobilised peripheral stem cell. | 2020 Sep |
1 |
| 12 |
31502114 | Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study. | 2019 Nov |
1 |
| 13 |
26586169 | Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis. | 2016 Apr |
1 |
| 14 |
26726942 | Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study. | 2016 Apr |
1 |
| 15 |
26764356 | Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation. | 2016 Mar 17 |
1 |
| 16 |
27470289 | Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions. | 2016 Oct |
1 |
| 17 |
27863757 | Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen? | 2016 Oct - Dec |
1 |
| 18 |
25293363 | Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma. | 2015 Jun |
2 |
| 19 |
25985920 | Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan. | 2015 Sep |
1 |
| 20 |
26176698 | Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation. | 2015 |
1 |
| 21 |
26228581 | Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience. | 2015 |
1 |
| 22 |
24595405 | Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. | 2014 Aug |
2 |
| 23 |
25330205 | Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis. | 2014 |
2 |
| 24 |
25489479 | Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma. | 2014 Dec |
1 |
| 25 |
22897584 | CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients. | 2013 May |
1 |
| 26 |
22111969 | Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice. | 2012 May |
1 |
| 27 |
22248715 | Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies. | 2012 Jul |
1 |
| 28 |
21617923 | Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab. | 2011 Oct |
1 |
| 29 |
19434371 | Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC regimen) in advanced malignancies. | 2010 Aug |
1 |
| 30 |
20133977 | Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis. | 2010 Jan-Feb |
2 |
| 31 |
18751888 | A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. | 2009 Jun |
1 |
| 32 |
18541199 | Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma. | 2008 Jul |
1 |
| 33 |
17284714 | Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. | 2007 Feb 7 |
1 |
| 34 |
17453364 | Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer. | 2007 |
1 |
| 35 |
17716984 | A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes. | 2007 Oct |
1 |
| 36 |
17923867 | Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group. | 2007 Nov 5 |
1 |
| 37 |
16769988 | Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? | 2006 Jul 1 |
3 |
| 38 |
17177909 | Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor. | 2006 Dec |
2 |
| 39 |
16172536 | Characterization of effector cells with anti-Candida activity obtained from murine bone marrow cells cultured in the presence of rhG-CSF: comparison between normal and CY-treated mice. | 2005 |
1 |
| 40 |
14726661 | A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer. | 2004 Jan |
1 |
| 41 |
14979480 | CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkin's lymphoma. | 2004 Jan |
2 |
| 42 |
15358478 | A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin. | 2004 Oct 15 |
1 |
| 43 |
15899616 | [Dose density and dose intensity in the treatment of breast cancer]. | 2004 Dec 1 |
1 |
| 44 |
12531794 | CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. | 2003 May 15 |
2 |
| 45 |
12542495 | Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. | 2003 Jan |
1 |
| 46 |
12621490 | Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. | 2003 Jan |
2 |
| 47 |
12663705 | Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. | 2003 Apr 1 |
3 |
| 48 |
12844025 | [Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration]. | 2003 Apr |
1 |
| 49 |
12915593 | CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. | 2003 Aug 15 |
1 |
| 50 |
14556916 | EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. | 2003 Nov |
1 |